ON 13 August 2021
Vaccine platform acronym – IV
Vaccine platform description –Inactivated virus
Type of candidate vaccine – CoronaVac; inactivated SARS-CoV-2 vaccine (vero cell)
Number of doses – 2
Schedule – Day 0 + 14
Route of administration – IM
Developers – Sinovac Research and Development Co., Ltd
Phase – Phase 4
Phase 1/2 – NCT04383574 | Study Report | NCT04352608 | Study Report | NCT04551547 | Study Report
Phase 2 –
Phase 2/3 – null
Phase 3 –
| NCT04456595 |
| Study Report |
| Study Protocol |
| NCT04508075 |
| NCT04582344 |
| Study report |
| NCT04617483 |
| NCT04651790 |
| Study Report |
Phase 4
| NCT04756830** |
| NCT04747821** |
| NCT04775069 |
| NCT04789356 |
| NCT04754698 |
| NCT04801888 |
| NCT04894227 |
| NCT04892459 |
| NCT04911790 |
| NCT04953325 |
| NCT04962308 |
Phase not reported
References:
